JPMorgan Chase (JPM)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-09-04
NYSEFinancialsBanks - DiversifiedSnapshot 2026-09-04
Research Workspace
Put JPM beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskHealthy across the board
JPMorgan's strong earnings growth and commitment to housing are key to its valuation. Revenue grew 27% year over year, and the last quarter beat expectations by 11%. It trades at 2.6× price-to-book versus a peer median of 1.3×, indicating it looks expensive based on peer multiples. A miss probability of 13% suggests risks to future performance. Peer multiples imply a price about 15% below where it trades. This read is provisional.
Trailing returns as of 2026-09-04. JPM is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering JPM (as of Sep 2026).
Based on 11 Wall Street analysts offering 12-month price targets for JPM in the last 4 months.
Continue this research
Compare JPM with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| JPM Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put JPM next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Maintain strong capital and liquidity position
Capital position concerns could impact future growth strategies.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $358.64
The last 12 months of price, then the range of analyst 12-month targets from today’s $358.64.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Higher rates may impact consumer borrowing and spending.

Potential partnership enhances investment banking revenue growth.

Advances: Increase net income and revenue growth
AI projects align with growth and innovation objectives.

Threatens: Expand Investment Banking and Markets revenue
Scaling back financing may hinder investment banking growth.

Advances: Expand Investment Banking and Markets revenue
Dealmaking growth supports Investment Banking revenue expansion.

Advances: Capital allocation: Increase dividend and authorize $50B share repurchase
Increased buybacks and dividends align with capital allocation goals.

Potential growth in payments aligns with revenue objectives.
